Although direct evidence of H4R expression in islets is lacking, blocking H4R with its selective antagonist JNJ-39758979 was efficient in the prevention of diabetic nephropathy progression (114), possibly by inhibiting inflammatory activities in tissues. Here, HRH4 is linked to diabetic kidney disease.